200 related articles for article (PubMed ID: 22273851)
1. Effects of cytochrome P450 1A1 and uridine-diphosphate-glucuronosyltransferase 1A1 allelic polymorphisms on the risk of development and the prognosis of head and neck cancers.
Szanyi I; Ráth G; Móricz P; Somogyvári K; Révész P; Gerlinger I; Orsós Z; Ember I; Kiss I
Eur J Cancer Prev; 2012 Nov; 21(6):560-8. PubMed ID: 22273851
[TBL] [Abstract][Full Text] [Related]
2. CYP1A1 gene polymorphism and risk of epithelial ovarian neoplasm.
Aktas D; Guney I; Alikasifoglu M; Yüce K; Tuncbilek E; Ayhan A
Gynecol Oncol; 2002 Aug; 86(2):124-8. PubMed ID: 12144816
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphisms of cytochrome P450 1A1 and risk of gallbladder cancer.
Tsuchiya Y; Sato T; Kiyohara C; Yoshida K; Ogoshi K; Nakamura K; Yamamoto M
J Exp Clin Cancer Res; 2002 Mar; 21(1):119-24. PubMed ID: 12071517
[TBL] [Abstract][Full Text] [Related]
4. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP
Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
[TBL] [Abstract][Full Text] [Related]
5. Smoking related risk involved in individuals carrying genetic variants of CYP1A1 gene in head and neck cancer.
Sabitha K; Reddy MV; Jamil K
Cancer Epidemiol; 2010 Oct; 34(5):587-92. PubMed ID: 20887941
[TBL] [Abstract][Full Text] [Related]
6. GSTM1, GSTT1, GSTP1, CYP1A1, and NAT1 polymorphisms, tobacco use, and the risk of head and neck cancer.
Olshan AF; Weissler MC; Watson MA; Bell DA
Cancer Epidemiol Biomarkers Prev; 2000 Feb; 9(2):185-91. PubMed ID: 10698480
[TBL] [Abstract][Full Text] [Related]
7. The effect of CYP1A1, GSTT1 and GSTM1 polymorphisms on the risk of lung cancer: a case-control study.
Atinkaya C; Taspinar M; Sakiragaoglu O; Oz G; Yazici U; Oztuna D; Tastepe I; Sunguroglu A
Hum Exp Toxicol; 2012 Oct; 31(10):1074-80. PubMed ID: 22893352
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population.
Nakachi K; Imai K; Hayashi S; Kawajiri K
Cancer Res; 1993 Jul; 53(13):2994-9. PubMed ID: 8319207
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphism in the conjugating enzyme UGT1A1 and the risk of head and neck cancer.
Lacko M; Roelofs HM; Te Morsche RH; Voogd AC; Ophuis MB; Peters WH; Manni JJ
Int J Cancer; 2010 Dec; 127(12):2815-21. PubMed ID: 21351260
[TBL] [Abstract][Full Text] [Related]
10. [Study on the association of cytochrome P450 polymorphisms and the risk of esophageal cancer: a meta-analysis].
Dai LP; Wang YP; Wu XB; Wang KJ; Lv QJ
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Nov; 30(11):1198-202. PubMed ID: 20193595
[TBL] [Abstract][Full Text] [Related]
11. Risk of non-small cell lung cancer and the cytochrome P4501A1 Ile462Val polymorphism.
Larsen JE; Colosimo ML; Yang IA; Bowman R; Zimmerman PV; Fong KM
Cancer Causes Control; 2005 Jun; 16(5):579-85. PubMed ID: 15986113
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms in CYP1A1 and breast carcinoma risk in a population-based case-control study of Chinese women.
Boyapati SM; Shu XO; Gao YT; Cai Q; Jin F; Zheng W
Cancer; 2005 Jun; 103(11):2228-35. PubMed ID: 15856430
[TBL] [Abstract][Full Text] [Related]
13. Promoter length polymorphism in UGT1A1 and the risk of sporadic colorectal cancer.
Bajro MH; Josifovski T; Panovski M; Jankulovski N; Nestorovska AK; Matevska N; Petrusevska N; Dimovski AJ
Cancer Genet; 2012 Apr; 205(4):163-7. PubMed ID: 22559977
[TBL] [Abstract][Full Text] [Related]
14. [Association of CYP1A1 Ile462Val polymorphisms with susceptibility to small cell lung cancer].
He B; Lin J; Cao L; Wang H; Rao J; Liu Y; Zhang Z
Wei Sheng Yan Jiu; 2014 May; 43(3):393-6, 418. PubMed ID: 24964616
[TBL] [Abstract][Full Text] [Related]
15. The effect of CYP1A1 and GSTM1 gene polymorphisms in bladder cancer development in a Turkish population.
Öztürk T; Kahraman ÖT; Toptaş B; Kisakesen Hİ; Çakalir C; Verim L; Öztürk O; İsbir T
In Vivo; 2011; 25(4):663-8. PubMed ID: 21709011
[TBL] [Abstract][Full Text] [Related]
16. Association of CYP1A1 Msp1 polymorphism with tobacco-related risk of gallbladder cancer in a north Indian population.
Pandey SN; Choudhuri G; Mittal B
Eur J Cancer Prev; 2008 Apr; 17(2):77-81. PubMed ID: 18287863
[TBL] [Abstract][Full Text] [Related]
17. Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: studies in upper aerodigestive tract cancers.
Matthias C; Bockmühl U; Jahnke V; Jones PW; Hayes JD; Alldersea J; Gilford J; Bailey L; Bath J; Worrall SF; Hand P; Fryer AA; Strange RC
Pharmacogenetics; 1998 Apr; 8(2):91-100. PubMed ID: 10022746
[TBL] [Abstract][Full Text] [Related]
18. CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma.
Gajecka M; Rydzanicz M; Jaskula-Sztul R; Kujawski M; Szyfter W; Szyfter K
Mutat Res; 2005 Jul; 574(1-2):112-23. PubMed ID: 15914211
[TBL] [Abstract][Full Text] [Related]
19. Glutathione S-transferase M1 and T1 and cytochrome P4501A1 polymorphisms in relation to the risk for benign and malignant head and neck lesions.
Oude Ophuis MB; van Lieshout EM; Roelofs HM; Peters WH; Manni JJ
Cancer; 1998 Mar; 82(5):936-43. PubMed ID: 9486585
[TBL] [Abstract][Full Text] [Related]
20. Association between UGT1A1 Polymorphism and Risk of Laryngeal Squamous Cell Carcinoma.
Huangfu H; Pan H; Wang B; Wen S; Han R; Li L
Int J Environ Res Public Health; 2016 Jan; 13(1):. PubMed ID: 26751466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
